Dr. Abbey Discusses New Treatment for Macular Telangiectasia Type 2
At AAO 2025, the American Academy of Ophthalmology’s annual meeting, Texas Retina’s Dr. Ashkan Abbey moderated a case-based roundtable discussion about the evolving landscape of macular telangiectasia (MacTel) type 2 care, including
read more
Happy Thanksgiving!
All Texas Retina Associates offices will be closed Thursday, November 27, and Friday, November 28, for the Thanksgiving holiday. During this time of reflection and gratitude, we want you to know how
read more
How Smoking Can Affect Your Eye Health
Today is the Great American Smokeout. Smoking remains the single largest cause of preventable disease and premature death in the United States. You probably know that smoking increases your risk of developing
read more
Celebrating Family Caregivers
Did you know that more than 63 million Americans are now caregivers? That is one in every four adults. In honor of National Family Caregivers Month, Texas Retina would like to recognize
read more
Happy Veterans Day!
On behalf of everyone at Texas Retina, we would like to extend our deepest gratitude for the sacrifices that our service members, both past and present, have made for our country.
read more
New Clinical Trials Available at Texas Retina
At Texas Retina, our physicians have participated in more than 100 national clinical trials over the past 20+ years, offering our patients access to promising new treatments for a variety of retina
read more
Dr. Ashkan Abbey Presented at the American Academy of Ophthalmology Annual Meeting
Texas Retina’s Ashkan M. Abbey, MD, presented, taught and served as a panelist at AAO 2025, the American Academy of Ophthalmology’s annual meeting held in Orlando, Florida, October 18-20, 2025. Highlights of
read more
Texas Retina’s Dr. Rene Choi Receives “One to Watch” Award at AAO 2025
“Dr. Rene Choi is an exceptional ophthalmologist, distinguished by his unwavering integrity and outstanding kindness and compassion towards his patients. He combines superb clinical and surgical skills in treating retinal and inflammatory
read more
Texas Retina Breaks Ground on New Frisco Ophthalmology Complex
We’re excited to announce that on October 14, 2025, Texas Retina broke ground on a new, state-of-the-art eye care complex to better serve the Frisco, Texas community. Scheduled to open in late 2026,
read more
Texas Retina Participating in New Phase III Clinical Trial for Uveal Melanoma
Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina will soon begin enrolling patients in the OptimUM-10 clinical trial, a randomized, Phase III, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic
read more